The role of GPER in CRC has garnered much interest as its expression predominates in colon cancer after the loss of nuclear ER, in particular after the loss of ERβ, which has been reported to negatively regulate GPER expression in breast cancer [177]. Here, ESR2 is linked to colorectal carcinoma.